- Home
- SONN vs WLGS Comparison
SONN vs WLGS Comparison
Compare SONN & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- WLGS
- Stock Information
- Founded
- SONN N/A
- WLGS 1981
- Country
- SONN United States
- WLGS Hong Kong
- Employees
- SONN N/A
- WLGS N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- WLGS Engineering & Construction
- Sector
- SONN Health Care
- WLGS Consumer Discretionary
- Exchange
- SONN Nasdaq
- WLGS Nasdaq
- Market Cap
- SONN 3.8M
- WLGS 4.2M
- IPO Year
- SONN N/A
- WLGS 2023
- Fundamental
- Price
- SONN $1.17
- WLGS $0.21
- Analyst Decision
- SONN Strong Buy
- WLGS
- Analyst Count
- SONN 1
- WLGS 0
- Target Price
- SONN $20.00
- WLGS N/A
- AVG Volume (30 Days)
- SONN 35.4K
- WLGS 29.5M
- Earning Date
- SONN 05-13-2025
- WLGS 06-10-2025
- Dividend Yield
- SONN N/A
- WLGS N/A
- EPS Growth
- SONN N/A
- WLGS N/A
- EPS
- SONN N/A
- WLGS N/A
- Revenue
- SONN $1,000,000.00
- WLGS $3,951,649.00
- Revenue This Year
- SONN $5,376.22
- WLGS N/A
- Revenue Next Year
- SONN N/A
- WLGS N/A
- P/E Ratio
- SONN N/A
- WLGS N/A
- Revenue Growth
- SONN 978.39
- WLGS N/A
- 52 Week Low
- SONN $1.08
- WLGS $0.15
- 52 Week High
- SONN $16.00
- WLGS $9.66
- Technical
- Relative Strength Index (RSI)
- SONN 41.48
- WLGS 34.30
- Support Level
- SONN $1.08
- WLGS $0.20
- Resistance Level
- SONN $1.21
- WLGS $0.28
- Average True Range (ATR)
- SONN 0.08
- WLGS 0.06
- MACD
- SONN -0.01
- WLGS 0.05
- Stochastic Oscillator
- SONN 30.00
- WLGS 8.54
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.